140 related articles for article (PubMed ID: 19674246)
1. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
Clin Neurol Neurosurg; 2009 Dec; 111(10):829-34. PubMed ID: 19735974
[TBL] [Abstract][Full Text] [Related]
4. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood.
Yoshinari S; Hamano S; Tanaka M; Minamitani M
Eur J Paediatr Neurol; 2006 May; 10(3):124-8. PubMed ID: 16757195
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
Waragai M; Ogawara K; Takaya Y; Hayashi M
Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of regional cerebral blood flow and distribution volume in Machado-Joseph disease by iodine-123I IMP single photon emission computed tomography].
Hayashi T; Nakajima T; Fukuhara N
Rinsho Shinkeigaku; 2001 Sep; 41(9):574-81. PubMed ID: 11968740
[TBL] [Abstract][Full Text] [Related]
8. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
[TBL] [Abstract][Full Text] [Related]
9. 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy.
Higashiyama S; Kawabe J; Hashimoto H; Akiyama H; Kawamura E; Torii K; Inoue K; Kiriike N; Shiomi S; Inoue Y
Osaka City Med J; 2006 Dec; 52(2):55-62. PubMed ID: 17330392
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral blood flow and developmental outcome in cryptogenic West syndrome.
Hamano S; Yoshinari S; Higurashi N; Tanaka M; Minamitani M; Eto Y
Epilepsia; 2007 Jan; 48(1):114-9. PubMed ID: 17241217
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6.
Honjo K; Ohshita T; Kawakami H; Naka H; Imon Y; Maruyama H; Mimori Y; Matsumoto M
Arch Neurol; 2004 Jun; 61(6):933-7. PubMed ID: 15210534
[TBL] [Abstract][Full Text] [Related]
12. Remote regional cerebral blood flow consequences of focused infarcts of the medulla, pons and cerebellum.
Rousseaux M; Steinling M
J Nucl Med; 1999 May; 40(5):721-9. PubMed ID: 10319742
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional stereotactic ROI template for measuring regional cerebral blood flow in 99mTc-ECD SPECT: comparison with the manual tracing method.
Nagasawa N; Yamakado K; Yamada T; Nakanishi S; Ito M; Suzawa N; Kitano T; Takeda K
Nucl Med Commun; 2009 Feb; 30(2):155-9. PubMed ID: 19077913
[TBL] [Abstract][Full Text] [Related]
14. Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles.
Furuta M; Sato M; Tsukagoshi S; Tsushima Y; Ikeda Y
J Neurol Sci; 2022 Jul; 438():120281. PubMed ID: 35609364
[TBL] [Abstract][Full Text] [Related]
15. Cerebellar blood perfusion is a diagnostic, but not a prognostic, marker for parkinsonian-dominant type multiple system atrophy.
Shiina K; Tsunemi T; Hattori N
Parkinsonism Relat Disord; 2024 Jun; 123():106975. PubMed ID: 38677216
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
Yoshida M; Nakanishi T; Komatsu Y
Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
[TBL] [Abstract][Full Text] [Related]
18. P300 and cerebral blood flow before and after TRH in olivopontocerebellar atrophy.
Mochizuki Y; Oishi M; Hara M; Takasu T
Int J Neurosci; 1997 Nov; 92(1-2):119-26. PubMed ID: 9522261
[TBL] [Abstract][Full Text] [Related]
19. Decreased cerebellar blood flow in postinfectious acute cerebellar ataxia.
Nagamitsu S; Matsuishi T; Ishibashi M; Yamashita Y; Nishimi T; Ichikawa K; Yamanishi K; Kato H
J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):109-12. PubMed ID: 10369834
[TBL] [Abstract][Full Text] [Related]
20. Brain perfusion differences in parkinsonian disorders.
Kimura N; Hanaki S; Masuda T; Hanaoka T; Hazama Y; Okazaki T; Arakawa R; Kumamoto T
Mov Disord; 2011 Dec; 26(14):2530-7. PubMed ID: 21830234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
